Using self-learning algorithms, DBL-4pen will bring most of the clinical improvement from DBLG1's closed-loop to insulin pen users, while the overall cost will be significantly lower for the payer.

Adapting today’s data and knowledge to tomorrow’s world Innovation programmes generally require extensive lab-environment testing and can take years before reaching the application stage. Sometimes, ...